Our Services
Medical Information
Helpful Resources
Published on: 7/9/2026
Melasma is a common skin condition that causes brown or grayish patches on the face, most often triggered by UV exposure, hormonal shifts (such as pregnancy or birth control), genetics, and irritating skincare products. Dermatologists agree that consistent sun protection is essential, alongside evidence-based topical treatments like hydroquinone, tretinoin, and combination creams.
Effective melasma management may also involve in-office procedures (such as chemical peels or lasers), oral therapies like tranexamic acid, and a long-term maintenance plan tailored to your skin.
Because melasma can mimic other pigmentation disorders and treatment success depends on identifying the right triggers, understanding your specific symptoms is critical. Take a free, instant, online symptom check to better understand what may be causing your skin changes and confidently navigate your next steps.
Reviewed for medical accuracy: 06/18/2026
Melasma is a common skin condition characterized by brown or gray-brown patches, usually on the cheeks, forehead, nose or upper lip. It affects up to 9 percent of adults, especially women of childbearing age and people with darker skin tones. While melasma isn't dangerous, it can impact self-esteem. Understanding the causes and evidence-based melasma treatment options can help you manage the condition effectively.
Melasma develops when melanocytes (pigment-producing cells) become overactive. Key triggers include:
Certain factors make melasma more likely:
Diagnosis is typically clinical. Your dermatologist will:
Once diagnosed, a personalized melasma treatment plan can begin.
Every dermatologist agrees: strict photoprotection is non-negotiable.
Without diligent sun protection, even the best melasma treatment won't hold results.
Dermatologists often prescribe a stepwise approach, starting with topical therapies:
Tips for topical use:
If topical melasma treatment alone is insufficient, dermatologists may add procedures:
Procedures often accelerate pigment fade when combined with strict sun protection and topicals.
For stubborn melasma, oral medications may be considered under medical supervision:
Oral therapies require close monitoring by a doctor for safety and efficacy.
Melasma is chronic and prone to relapse. A lifelong maintenance plan helps sustain results:
Be honest about costs, time commitment and potential side effects. Open communication with your dermatologist helps tailor realistic goals.
While melasma isn't life-threatening, new or changing pigmentation should be evaluated. If you notice:
…you should speak to a doctor immediately. If you're experiencing concerning skin symptoms or unusual pigmentation changes and want to better understand what might be happening before your dermatology appointment, you can use this free AI Symptom Checker to help identify possible causes and determine how urgently you should seek care.
Melasma can be challenging, but with a consistent, dermatologist-guided melasma treatment plan, many patients achieve significant lightening and improved confidence. If you have any serious or concerning symptoms, don't hesitate to speak to a doctor.
(References)
* Mermelstein L, Nambudiri VE. Melasma: a systematic review of its etiopathogenesis, clinical diagnosis, and treatment. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):31-43.
* Sheth VM, Pandya AG, Dongre R, Goel S, Bhattacharjee R. Melasma: a comprehensive update on diagnosis and treatment. G Ital Dermatol Venereol. 2023 Apr;158(2):93-107.
* Lee JJ, Kashiwagi N, Rosman IS, Council ML, Mann MW, Anumolu B, Anumolu A, Kwong BY, Milstone LM, Schlessinger DI. Melasma treatment: a systematic review of the efficacy and safety of current therapies. J Am Acad Dermatol. 2023 Feb;88(2):418-428.
* Handel AC, de Arruda LH, Miot HA. New insights into the pathogenesis of melasma. J Am Acad Dermatol. 2023 May;88(5):1075-1082.
* Sarkar R, Ghunawat S, Agarwal P, Singh A, Kumaran MS, Podder I, Aurangabadkar S, Bhattacharjee P, Bhattacharya S, Chauhan P, D'Souza P, Gangaram D, Ganesh T, Ghoshal A, Gupta V, Jindal A, Lahiri K, Majumdar P, Makhecha D, Mahajan A, Mehta S, Mehta S, Panda S, Pradhan A, Rath SK, Saha M, Sandhu D, Saraswat PK, Sarvjot K, Singh S, Singh V, Sinha A, Vadlamudi N, Yadav S. Consensus recommendations on melasma management in Indian patients. Indian J Dermatol Venereol. 2021 May-Jun;87(3):308-316.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.